pKI-cjACTB-IRES-ERT2CreERT2-IRES-Hyg
(Plasmid
#159927)
-
PurposeGene targeting
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 159927 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRoxTV
-
Vector typeMarmoset Targeting
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameERT2CreERT2
-
SpeciesSynthetic
-
Insert Size (bp)2925
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pKI-cjACTB-IRES-ERT2CreERT2-IRES-Hyg was a gift from Hideyuki Okano (Addgene plasmid # 159927 ; http://n2t.net/addgene:159927 ; RRID:Addgene_159927) -
For your References section:
Generation and validation of a common marmoset embryonic stem cell line ActiCre-B1 that ubiquitously expresses a tamoxifen-inducible Cre-driver. Yoshimatsu S, Ohtsu K, Sato T, Yamamoto M, Sasaki E, Shiozawa S, Okano H. Stem Cell Res. 2021 Jan 8;51:102164. doi: 10.1016/j.scr.2021.102164. 10.1016/j.scr.2021.102164 PubMed 33453576